AGC
ORGO icon

Angelo Gordon & Co’s Organogenesis Holdings ORGO Stock Holding History

Angelo Gordon & Co’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-148,192
Closed -$974K – 72
2019
Q3 		$974K Buy
+148,192
New +$825K 0.12% 72
2018
Q3 		– Sell
-1,771,123
Closed -$17.8M – 96
2018
Q2 		$17.8M Sell
1,771,123
-100,000
-5% -$1M 1.14% 27
2018
Q1 		$18.7M Hold
1,871,123
– – 0.99% 29
2017
Q4 		$18.6M Buy
+1,871,123
New +$18.6M 1.02% 28

Other funds holding ORGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Angelo Gordon & Co's ORGO Position: Q4 2019 in Review

Angelo Gordon & Co sold out of Organogenesis Holdings (ORGO) in Q4 2019, closing a stake of 148,192 shares — an estimated $974K sold.

Angelo Gordon & Co first reported a position in ORGO in Q4 2017 and held it in 4 quarters. The position peaked at $18.7M in Q1 2018. 55 funds tracked by Wall St. Rank hold ORGO as of Q4 2019.

  • Angelo Gordon & Co reported no remaining Organogenesis Holdings position as of Q4 2019 after selling out during the quarter.
  • Angelo Gordon & Co sold 148,192 Organogenesis Holdings shares in Q4 2019, an estimated $974K.
  • Angelo Gordon & Co first reported a position in Organogenesis Holdings in Q4 2017 and held it in 4 quarters.
  • Angelo Gordon & Co's Organogenesis Holdings position peaked at $18.7M in Q1 2018.
  • 55 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2019.

Based on Angelo Gordon & Co's 13F filing for Q4 2019, filed 14 Feb 2020.